Ovid Therapeutics Inc. · NASDAQ:OVID
Affinity Asset Advisors, LLC reported a 9.00% stake in Ovid Therapeutics Inc. (Schedule 13G/A)
Event Jan 22, 2026 · Filed Jan 29, 2026
Affinity Asset Advisors, LLC reported a 9.00% stake in Ovid Therapeutics Inc., 12,149,166 shares, as a passive investor on Jan 22, 2026. Filed Jan 29, 2026 (Schedule 13G/A).
- Stake
- 9.00%
- Shares
- 12,149,166
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Affinity Asset Advisors, LLC | 9.00% | 12,149,166 |
| Michael Cho | 9.00% | 12,149,166 |
Source
Related
- Ovid Therapeutics Inc.
- Affinity Asset Advisors, LLC
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · May 14, 2026
- Schedule 13G · Affinity Asset Advisors, LLC · Dec 18, 2025
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026